Sporadic Papillary Renal Cell Carcinoma
1 clinical trials · Condition
◉ Watch Sporadic Papillary Renal Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer (NCT04981509) | National Cancer Institute (NCI) | 2022-06-10 |
Track Sporadic Papillary Renal Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.